BioCryst Pharmaceuticals, Inc.

The US Food and Drug Administration’s June user fee goal calendar reflects the gravitational pull of major meetings. The month opens with the monster American Society of Clinical Oncology annual meeti

There are pivotal moments that stick in the mind of any longtime CEO. Some are good, some are bad, all are memorable. For Bill Burns, three defining snapshots encapsulate the highs and lows of his nin

There are pivotal moments that stick in the mind of any longtime CEO. Some are good, some are bad, all are memorable. For Bill Burns, three defining snapshots encapsulate the highs and lows of his nin

Ionis has brought products to market under partnerships – namely Biogen’s spinal muscular atrophy drug Spinraza (nusinersen) and the recently launched transthyretin amyloidosis drug Wainua (eplonterse